Oncologica is a leading laboratory in genetic cancer testing. We help patients and oncologists to get the maximum benefit from new cancer treatments.

Immune system and cancer

Are you interested in knowing which DNA tests are best indicated for a specific medical case??

The immune system keeps track of all of the cells and substances normally found in the human body, if there is a new substance that the immune system doesn’t recognize, this raises an alarm, causing the immune system to immediately attack it.

It is clear that there are limits on the immune system’s ability to fight cancer on its own, because many people with healthy immune systems still develop cancer

Limits of immune response to cancer growth

\

The immune system doesn’t detect the cancer cells as foreign

\

The immune system recognizes the cancer cells, but the immuno response might not be enough to destroy the cancer.

\

Cancer cells emit substances that keep the immune system from finding and attacking them.

Role of immunotheraphy drugs

Researchers have found ways to help the immune system recognize cancer cells and strengthen its response so that it will destroy them.

Immunotherapy drugs have been proven to be effective in prolonging the lives of patients with advanced cancers but with far less toxic side effects than chemotherapy, but not all patient are eligible for these new therapies.

Oncologica’s DNA tests are used by patients and clinicians to predict the response to immunotherapy, thus expanding the patient’s treatment options.

Powerful, less toxic but very specific.

Immunotherapy doesn’t work the same for everyone: in some patients it appears to work incredibility well, completely destroying tumours, for other patients, the response can be less dramatic.

Before assessing whether the patient is eligible for these new treatment options it is therefore essential to first identify whether the patient will benefit from from such therapy.

Immunotherapy AVG. RESPONSE

A routine DNA test to identify Eligible Patients

Oncologica helps patients and clinicians to expand their treatment options by using precision oncology tests.

Immunofocus PD1 and TMB are DNA tests based on clinical evidence, that can be performed on the normal histological samples to predict the response to immunotherapy, thus expanding the patient’s treatment options.

Get a free consultancy on precision oncology

Get in touch with our clinical team to learn about the benefits of precision oncology.

    If you want you can provide further details about the clinical case by replying to the email that our clinical team will send you.

    The information transmitted is used exclusively to process your request. By submitting this form you accept the terms and conditions including our Privacy Policy. At any time you can ask for your personal data to be deleted and removed.

    This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

    Accept Privacy Policy

    s

    Note to patients: All contents on this page are for informational purposes. Decisions regarding medical treatments and diagnoses must always be made in consultation with your treating clinician.

    More to read and watch
    on precision oncology

    The Business Post

    Oncologica® has developed a DNA test which allows medical professionals select the appropriate precision cancer treatment to defeat tumours.

    The Business Post

    Cambridge News

    Dad with terminal cancer given hope by ground-breaking precision oncology test.

    Cambridge News

    Oncologica® is a leading precision oncology certified laboratory based in the prestigious Chesterford Research Park, Cambridge, UK.

    Since 2015 we have been helping oncologists and patients every day to get the maximum benefit from new advanced genetic profiling techniques for the treatment of cancer.

    Oncologica® UK ltd.
    Suite 15-16 The Science Village, Chesterford Research Park, Little Chesterford, Cambridge, CB10 1XL
    +44 (0) 1223 785327